Funding to address one of drug discovery’s most critical bottlenecks by developing small-molecule drugs for historically ...
UAE-based CE‑Ventures, the VC arm of Crescent Enterprises, has participated in a $55 million Series A funding round for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback